Abstract Cadmium (Cd), a carcinogenic component of tobacco, is a recognized risk factor for oral squamous cell carcinoma (OSCC). However, the molecular mechanisms underlying Cd-induced cytotoxicity in OSCC remain largely undefined. Here, we demonstrate that acute Cd exposure triggers ferroptosis in CAL27 OSCC cells derived from never-smokers, but not in SCC154 cells derived from smokers. Mechanistically, Cd outcompetes Fe, causing early iron depletion and activating the nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy. This process enhances the labile iron pool, promotes mitochondrial reactive oxygen species (ROS) generation, lipid peroxidation, and ferroptotic cell death. Notably, iron supplementation rescues CAL27 cells from Cd-induced damage, while exacerbating iron deficiency through transferrin receptor CD71 silencing amplifies cytotoxicity. Conversely, OSCC cells from smokers exhibit resistance to Cd toxicity, likely due to the overexpression of metallothionein 2A (MT2A), a heavy metal detoxification protein. Collectively, this study provides the evidence that ferritinophagy may act as a critical upstream driver of Cd-induced ferroptosis in OSCC cells derived from never-smokers, paving the way for potential ferroptosis-targeted therapeutic strategies in Cd-associated malignancies. Keywords: Cadmium, Ferroptosis, Ferritinophagy, NCOA4, Oral Cancer, Iron Metabolism, Smokers Introduction The homeostasis of intracellular metal ions is essential for maintaining cellular integrity and function. However, disturbances in metal balance can trigger a cascade of toxic events, including oxidative damage to proteins and DNA, disruption of cell membranes, and activation of regulated cell death (RCD) pathways [59]^1^,[60]^2. In recent years, a growing body of evidence has delineated distinct forms of metals-induced RCD, namely ferroptosis, cuproptosis, and calcicoptosis, each characterized by the accumulation of specific divalent cations, namely iron (Fe²⁺), copper (Cu²⁺), and calcium (Ca²⁺), respectively [61]^3^,[62]^4. In addition, exogenous metals such as zinc (Zn²⁺), manganese (Mn²⁺), and cadmium (Cd²⁺) have been shown to induce cell death through context-dependent mechanisms, often converging on oxidative stress and mitochondrial dysfunction [63]^5^,[64]^6. Cd^2+ is a well-recognized environmental pollutant, primarily originating from industrial processes, agricultural activities, and tobacco-consumption [65]^5^,[66]^7^-[67]^9. Although Cd^2+ is a non-Fenton-like metal and does not directly generate reactive oxygen species (ROS), it can induce oxidative stress through several indirect mechanisms [68]^10^,[69]^11. These include (i) depletion of antioxidant molecules such as glutathione (GSH), (ii) inhibition of ROS-detoxifying enzymes, (iii) displacement of essential redox-active metals (Zn²⁺ and Fe²⁺), and (iv) impairment of mitochondrial electron transport chain, collectively resulting in mitochondrial dysfunction and ROS overproduction [70]^10^-[71]^13. Cd²⁺-induced oxidative stress has been recognized as a key driver of several pathological conditions, including cancer [72]^12^-[73]^17. In 1993, indeed, the International Agency for Research on Cancer (IARC) classified Cd²⁺ as a Group 1 carcinogen [74]^18. Mechanistically, Cd^2+ exerts its carcinogenic activity through multiple pathways, including the induction of oxidative DNA damage in the form of DNA mutation, strand breaks, and chromosomal aberrations, as well as the inhibition of DNA repair systems - notably through suppression of p53 DNA binding capacity and the suppression of DNA repair-associated genes [75]^19^-[76]^21. Beyond its genotoxic effect, Cd^2+ also exerts epigenetic effects by altering DNA and histone methylation patterns. For instance, Cd^2+-induced hypermethylation of tumor suppressor genes promoters, such as p16, has been associated with malignant transformation of human prostate epithelial cells [77]^22. Furthermore, chronic exposure to sub-toxic concentrations of Cd^2+ can activate defense mechanisms against oxidative stress, including the stimulation of ROS-sensitive transcription factors, such as nuclear factor erythroid 2-related factor 2 (Nrf2), activator protein 1 (AP-1) and nuclear factor-kB (NF-kB), as well as mitogen-activated protein kinases (MAPKs)- dependent signaling pathways, which may ultimately promote cell survival and tumorigenesis [78]^23^-[79]^25. Over time, epidemiological studies have reported a significant association between Cd²⁺ exposure and increased risk of oral squamous cell carcinoma (OSCC), the most common subtype of head and neck squamous cell carcinoma (HNSCC) [80]^26^-[81]^28. In this context, both environmental factors and genetic alterations in oncogenes and tumor suppressor genes play central roles in OSCC pathogenesis [82]^29^-[83]^33. Notably, chronic and prolonged exposure to Cd^2+ - particularly through tobacco consumption - appears to contribute to carcinogenic transformation of the oral epithelial mucosa [84]^9^,[85]^30^,[86]^34^-[87]^37. However, the molecular mechanism underlying the Cd^2+-induced toxicity in oral epithelial cells remains incompletely understood and requires further study. In this study, we investigated the effects of Cd²⁺ acute exposure in OSCC cells derived from non-smoker and smoker patients - the latter being chronically exposed to roughly 4-5 times higher levels of Cd²⁺ compared to non-smokers. Our findings reveal that Cd²⁺ toxicity selectively affects OSCC cells derived from non-smokers whereas OSCC cells derived from smokers display resistance, likely due to the overexpression of the heavy metal detoxification protein metallothionein 2A (MT2A). Notably, we demonstrate for the first time that, in OSCC cells derived from non-smokers, ferroptosis is involved in Cd²⁺-induced cytotoxicity. Mechanistically, Cd^2+ outcompetes Fe, thus leading to an early iron depletion, which in turn acts as a driving force for the nuclear receptor coactivator 4 (NCOA4)- mediated autophagic degradation of ferritin (ferritinohagy). Ferritinophagy, subsequently, determines an increase in labile iron pool (LIP), mitochondrial ROS production, and lipid peroxidation. Overall, this study uncovers a novel mechanism of Cd-induced cytotoxicity in OSCC cells, providing a basis for developing ferroptosis-based therapeutic strategies for Cd-associated diseases. Materials and Methods Cell lines and cell culture Human oral squamous cell lines (OSCC) - CAL27, OT1109, SCC090, and SCC154 - were purchased from the American Type Culture Collection (ATCC, Rockville, MD, United States). CAL27 and OT1109 cells were derived from never-smoker patients, while SCC090 and SCC154 originated from tobacco users. Following ATCC instruction, CAL27 cells were grown in DMEM medium (Sigma-Aldrich, St. Louis, Missouri, United States ), while SCC154 cells were cultured in MEM (Sigma-Aldrich, St. Louis, Missouri, United States), both supplemented with 10% (v/v) fetal bovine serum (FBS) (Invitrogen, San Diego, CA), L-glutamine and 1% (v/v) penicillin and streptomycin (Sigma-Aldrich, St. Louis, Missouri, United States) at 37°C in a humidified incubator with 5% CO[2] atmosphere. All cell lines were tested for mycoplasma contaminations and authenticated via short tandem repeat (STR) profiling. Reagents and treatments Cadmium chloride (CdCl[2]), ferrostatin-1 (Fer-1) and bafilomycin (Baf) were purchased from Sigma Aldrich (Sigma-Aldrich, St. Louis, MO, USA). Ferlixit (62.5 mg/5 mL, sodium ferric gluconate complex in sucrose, SANOFI) has been obtained from the outpatient pharmacy at the Unit of Cardiology, “Magna Graecia” University of Catanzaro. Cells were seeded in a 12- and 6-well plate in complete medium. Each compound was used at the following final concentrations: CdCl[2] at 0.1, 1, 5, 10, 50 and 100μM for 12h; CdCl[2] at 26.1μM for 30', 1h, 6h and 12h; Fer-1 at 100μM for 24h; Baf at 1μM for 12h; ferlixit at 25, 50 and 100μM for 12h. Treatments were performed at least three times on independent biological replicates. CAL27 were exposed to 10μM CdCl[2] for 30 days to induce metal tolerance (CAL27T); this concentration was replenished every 2-3 passages to maintain tolerance. Patients and clinical samples Fourteen OSCC patients, 7 non-smokers and 7 smokers, underwent surgery at the Oral Pathology and Oral Surgery Unit of “Magna Graecia” University, between December 2020 and December 2022 [88]^32^,[89]^33. For each patient, primary tumor tissue specimens were collected within the macroscopic lesion boundaries defined visually and by palpation. All patients provided a written informed consent at the time of data collection. No information that could identify individual participants are available. The procedures reported in this study were performed in accordance with the Helsinki Declaration guidelines (2008) on human experimentation and good clinical practice (good clinical practice or GCP). PI staining analysis Cells were incubated with propidium iodide (PI) at 37°C for 15 min in the dark, washed twice with PBS, and analyzed using a BD LSRFortessa™ X-20 flow cytometer (BD Biosciences, San Jose, CA, USA). A total of 2×10^4 events were acquired for each sample. Data analysis was carried out using FlowJo™ v10 Software (BD Biosciences, San Jose, CA). Each experiment was performed in triplicate. Apoptosis assay Apoptotic cells populations were identified using the Alexa Fluor®488 Annexin V/Dead Cell Apoptosis Kit (Thermo Fisher Scientific, Waltham, MA, USA [90]^38. Briefly, 1×10^5 single-cell suspensions from CAL27 and SCC154 cell lines were centrifuged and resuspended in 100μL 1X annexin-binding buffer. To each sample, 5μL Alexa Fluor®488 Annexin V and 1μL PI working solution (100μg/mL) were added. Samples were then incubated for 15' at room temperature in the dark. Each tube was diluted with 200 μL of Annexin Binding Buffer. Flow cytometry assays were performed using the BD LSRFortessa™ X-20 (BD Biosciences, San Jose, CA, USA). Data were acquired from three independent biological replicates and analyzed out using FlowJo™ v10 Software (BD Biosciences, San Jose, CA). Cell viability assay (MTT) Cell viability was assessed using the 3-[4,5-dimethylthiazolyl]-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-Aldrich, St. Louis, MO, USA) assay. Briefly, CAL27 and SCC154 cells (5 × 10^4 cells/well) were seeded in a 24-well plates. Following exposure to CdCl[2], cells were incubated with freshly prepared MTT solution (2 mg/mL) for 4h at 37 °C. Then, the supernatant was removed and replaced with 200μL of isopropanol to solubilize the resulting formazan crystals. Absorbance was measured at 595nm using a microplate spectrophotometer. Cell viability was expressed as a percentage relative to untreated control cells, which were set as 100%. The assay was performed at 0, 12, and 24h post-treatment. All experimental conditions were tested in triplicate across three independent experiments. Wound healing assay Cells (3 × 10⁵) were seeded in 12-well plates. A scratch was introduced using a sterile pipette tip, and wound closure was monitored at 0, 12, 24, 48, and 72 h using using the Leica THUNDER Microscope DMi8 (Leica Microsystems S.r.l., Wetzlar, Germany). The gap area was quantified using by using ImageJ software. All experiments were conducted in triplicate. Total protein extraction and western Blot analysis Total protein extracts were prepared using RIPA lysis buffer composed of 1M Tris HCl, Triton X-100, 3M NaCl, 0.5M EDTA, 10% SDS supplemented with cOmplete™ Protease Inhibitor Cocktail provided in EASYpacks (Roche Diagnostics, Mannheim, Germany) to prevent proteolytic degradation [91]^39. Briefly, cells were lysed in ice-cold RIPA buffer and lysates were centrifuged at 12.000g for 30' at 4°C to remove insoluble debris. Protein concentration was determined using the Bio-Rad Protein Assay Dye according to manufacturer's instructions (Bio-Rad Laboratories, Hercules, California, United States). Equal amounts of protein (50μg) from each sample were separated by 8%-12% SDS-PAGE, run at 200V for 1h and 30'. Proteins were then transferred onto nitrocellulose membranes (Sigma-Aldrich, St. Louis, MO, United States) at 50V for 2h. Membranes were blocked with 5% non-fat milk or 5% BSA for 1h at room temperature, followed by overnight incubation at 4°C with the appropriate primary antibodies. The antibodies against ferritin heavy subunit (FtH1) (1:200, sc-376594), NCOA4 (1:500, sc-373739) and hypoxia inducible factor-1 alpha (HIF-1ɑ) (1:500, sc-10790) were purchased from Santa Cruz Biotechnology (Santa Cruz Biotechnology, Dallas, Texas, United States); antibody against glutathione peroxidase 4 (GPX4) (1:1000, ab19534) was purchased from Abcam (Abcam, Cambridge, UK), while antibodies against mechanistic target of rapamycin complex 1 (mTORC1) (1:500, 2972s), phosphorylated mTORC1 (p-mTORC1) (1:500, 5536s), microtubule associated protein 1 light chain 3B (LC3B) (1:500, #2775) and iron regulatory protein 1 (IRP1) (1:1000, 20272) were obtained from Cell Signaling Technology (Danvers, Massachusetts, United States). Membranes were washed for 30' and then incubated for 1h at room temperature with peroxidase-conjugated secondary antibodies (Peroxidase AffiniPure Sheep Anti-Mouse IgG, 1:10,000; Peroxidase AffiniPure Donkey Anti-Rabbit IgG, 1:10,000; Peroxidase AffiniPure Donkey Anti-Goat IgG, 1:10,000; Jackson ImmunoResearch Europe Ltd). Signals were detected using chemiluminescence reagents (ECL Western blotting detection system, Santa Cruz Biotechnology, Dallas, Texas) and acquired by Uvitec Alliance Mini HD9 (Uvitec Cambridge, United Kingdom). To calculate the relative expression of specific protein a mouse monoclonal IgG glyceraldehyde 3-phosphate dehydrogenase (GAPDH) HRP (1:3000; sc-47724) serves as references for sample loading. The protein band intensity on